Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations

Figures & data

Table 1.  Demographic characteristics of the study participants

Number of COPD patients	n = 90
Sex. M/F	67/23
	Mean	(± SD)
Age	69.64	9.93
Days of hospitalization	10.92	12.00
FEV1/FVC	55.46	11.48
FEF25-75	22.73	14.39
FEV1 (lt)	0.60	0.41
PO2	56.67	13.02
PCO2	50.13	17.12
pH	7.39	0.06
SatO2	86.34	7.51
Hct (%)	41.71	5.46
Hb	13.51	1.90
WBC	11091.48	4002.37
TotalProtein	6.99	0.84
Albumin	3.63	0.53

Data are presented as mean ± SD.

Figure 1.  Serum Angiopoietin-2 on days 1 (ANG1) and 7 (ANG7) - paired samples.

Figure 1a. Serum Angiopoietin-2 on days 1 (ANG1) and 7 (ANG7) - scatterplot (horizontal lines represent mean values).

Figure 2.  Serum C-reactive protein (CRP) on days 1 (CRP1) and 7 (CRP7) - paired samples.

Figure 2a. Serum C-reactive protein (CRP) on days 1 (CRP1) and 7 (CRP7) - scatterplot (horizontal lines represent mean values).

Table 2.  Comparison of serum Ang-2 and CRP levels between patients with favorable and unfavorable outcome

	Favorable Outcome(n = 79)	Unfavorable Outcome(n = 11)	p-value
Ang-2 D1	2974.4 ± 1744.3	4644.9 ± 2493.7	0.04
Ang-2 D7	1957.1 ± 1182.5	3447.7 ± 2060.5	0.01
CRP D1	4.9 ± 6.4	4.6 ± 5.2	NS
CRP D7	1.29 ± 2.8	5.76 ± 6.7	0.00